A case is reported in which metoclopramide, midazolam, propofol, and pethidine were injected arterially during the course of anaesthesia, resulting in oedema and discolouration of the hand initially, but no long-term sequelae. An AVI 470 pump (3M Corporation) was used to control the infusion, and prevented backflow through a cannula which was unintentionally sited in an artery rather than a vein. Few anaesthetic drugs have their effects well documented when given arterially, and in particular, there were no previous reported cases involving metoclopramide in this context. The pharmacology of metoclopramide is discussed with reference to the drug's known effects on vascular beds and platelet function.
Intra-arterial injection of therapeutic drugs may be accompanied by serious complications, including vascular endothelial destruction and tissue necrosis 1 . Commercial testing for arterial tolerability in humans is consequently unethical unless this is the intended route of administration, and we must rely on sporadic case reports to assist with management of inadvertent intra-arterial drug deposition.
CASE REPORT
A 16-year-old female patient with type 1 diabetes mellitus was booked as an emergency case for removal of a broken insulin needle from her abdominal wall. She was mildly distressed following an unsuccessful attempt to remove it under local anaesthesia in the Emergency Department. The patient was fasted, and arrived in the operating theatre with 5% dextrose running into a 20 gauge cannula sited at the right wrist, approximately 3 cm proximal to the anatomical snuffbox. An AVI 470 pump (3M Corporation) controlled the infusion, and its occlusion-sensing device did not alarm during use.
Shortly before induction, she was given midazolam 1.5 mg and metoclopramide 10 mg via an Interlink needleless injection port, with the dextrose solution still running. No adverse effect was noted. After preoxygenation, injection of propofol 5 ml resulted in strong pain around the injection site, despite an expected reduction in this problem following the use of metoclopramide 2,3 . Waiting a short time and injecting more slowly resulted in the same problem: consequently, induction was completed using sevoflurane in oxygen and nitrous oxide. A laryngeal mask was inserted and 50 mg of pethidine was injected via the cannula. Anaesthesia then proceeded uneventfully with spontaneous ventilation.
Recovery ward staff sought advice postoperatively when the first and second digits of her right hand reportedly became swollen, erythematous and painful after a further injection of pethidine. On review, arterial cannula placement was suspected due to these signs being distal to the cannula, and the diagnosis was confirmed by connecting an open length of intravenous infusion tubing to the cannula with the pump switched off. Pulsatile blood coursed up the tubing to indicate a pressure significantly above expected venous pressure. Her hand displayed a yellow/white discolouration with slight oedema and related stiffness, but digital perfusion was clinically adequate. In the absence of definite indications for vasodilator or anticoagulant drugs, and lacking drug company information about the effects of these drugs injected arterially, the cannula was removed to facilitate flow through the vessel. Review four hours later found her hand to be swollen, with pitting oedema, but pink in colour with a capillary refill time of three seconds. She was able to curl her hand into a fist, a manoeuvre which she could not perform immediately after the incident.
She remained in hospital overnight with her arm elevated in a sling, and her condition showed continued improvement. Hospital discharge occurred later the next day. Follow-up at one week indicated return to normal function and appearance.
DISCUSSION
The outcome in this case was satisfactory, although severe upper extremity ischaemia has been reported following intra-arterial pethidine injection of unspecified purity in relation to drug abuse. Vasospasm was postulated as a contributing factor along with the more traditional mechanisms of thrombosis and endarteritis 4 .
Intra-arterial propofol injection has been reported a number of times in humans without long term damage 1, 5, 6, 7 . The usual response is distal hyperaemia, although a short period of vasoconstriction may occur initially. A toxicity study using propofol in animals has shown no evidence of direct toxicity to the arterial endothelium 1 . Direct arterial injection of midazolam has also been reported without serious effects 8 .
Brief duration arterial infusion of metoclopramide in humans has been reported, at a rate of 10 µg/min via the brachial artery during investigation of peripheral vascular dopamine receptors 9, 10 . The dose used was calculated to produce DA-2 (dopamine) antagonism, and did not cause detectable changes in blood flow. The drug has effects at multiple receptor subtypes however, and those with lesser affinity will be important where high local concentrations are obtained. Primarily a DA-2 and 5HT2 (serotonin) receptor antagonist [10] [11] [12] , metoclopramide has lesser effects as a DA-1 (dopamine), alpha-2 and 5HT-3 antagonist 10,13-15 , as well as being a 5HT-1 and 5HT-4 partial agonist [16] [17] [18] . With high metoclopramide concentrations and an intact vascular endothelium, DA-1, DA-2 and alpha-2 receptor effects will promote a minor degree of vasoconstriction 10, 19 , the latter two acting indirectly via modulation of peripheral noradrenergic pathways. These effects will be countered by 5HT-2 receptor mediated vasodilatation, a response which is enhanced where the endothelium has been damaged 20,21 . 5HT-1 agonists cause a minor degree of peripheral vasoconstriction 22 , but the role of peripheral 5HT-1 receptors in this action is unclear 23 . No evidence for a role in human peripheral vasculature was found for 5HT-3 and 5HT-4 receptors. Platelet-induced vasoconstriction in human radial artery tissue is inhibited by 5HT-2 blockade 21 , and platelet activation in a rat model of arterial thrombosis is significantly decreased by metoclopramide 12 . The latter effect may be related to both 5HT-2 and alpha-2 receptor antagonism 11 . The "Maxolon" (DermaTech) preparation of metoclopramide used in this case also contains the preservative sodium metabisulfite. This substance has been shown to cause reversible vasoconstriction in humans 24 , but tissue infiltration at the usual concentrations has not reliably been shown to cause tissue damage in animal studies, despite a pH lowering effect 25, 26 .
The initial dosing with metoclopramide may have been protective in this instance, decreasing vasospastic and thrombotic phenomena such that no visible response occurred with any of the drugs given initially. Repeat dosage of pethidine in the recovery room at a later stage gave rise to the observed changes, which finally exposed the problem. The treatment chronology and previously documented incidents suggest that the clinical changes in this case were pethidine related.
This report should highlight the need for vigilance during cannulation, particularly when the chosen site is adjacent to known sites of aberrant branches of arteries. Any undue pain on intravenous injection warrants exclusion of an incorrectly positioned cannula as the cause. In this instance, the diagnosis was delayed by the use of an infusion pump, which prevented backflow in the tubing, and did not give any indication that it was operating against an arterial pressure. Reviewing the technical data for the device revealed that it has a user-adjustable occlusion sensor with two possible settings. Even on the more sensitive of these settings, an alarm will not occur until a backpressure of around 200 mmHg is reached, so it is not surprising that the patient's blood pressure did not trigger it. It would appear prudent to remove the tubing temporarily from the pump to assess flow, even when the volumetric function is required. During this manoeuvre an arterially sited cannula will not permit inward flow and may exhibit backflow, unless the height of the fluid column connected is greater than the arterial pressure measured against fluid of equal density.
